Related Experiment Video
Updated: Feb 11, 2026

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
Medication Use in Women and Men With Sudden Unexpected Death
Sonalie Patel1, Mitchell M Conover2, Golsa Joodi3
11 University of North Carolina Medical Center, Chapel Hill, NC, USA.
Insights
Sudden unexpected death is common in Wake County, NC. Evidence-based medication use was low, indicating a need for improved prescribing practices to prevent cardiovascular events.
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Sudden unexpected death (SUD) represents 10-15% of natural deaths in adults aged 18-64 in Wake County, NC.
- Guidelines recommend medications like aspirin, ACE inhibitors, ARBs, statins, and beta-blockers to reduce cardiovascular events and SUD.
- Underpractice of these guideline-directed therapies is noted, with disparities observed in women.
Purpose of the Study:
- To assess the relationship between the prescription of evidence-based medications and sudden unexpected death in Wake County, NC.
Main Methods:
- Analysis of 399 sudden unexpected death cases from March 1, 2013, to February 28, 2015.
- Medication assessment from medical examiner reports and records, categorized using Anatomical Therapeutic Chemical (ATC) codes.
- Study reviewed and deemed exempt by the University of North Carolina's institutional review board.
Main Results:
- Women (126) were prescribed more medications overall than men (273) (6.5 vs. 4.3, P=0.001).
- No significant difference in guideline-directed therapy use between genders for chronic conditions linked to SUD.
- Overall utilization of evidence-based medications was notably low.
Conclusions:
- Findings underscore the critical need to enhance the prescription of evidence-based medications.
- Further research is required to explore the link between undertreatment and sudden unexpected death.
- Improving medication adherence and access may reduce cardiovascular mortality.
Background:
In Wake County, NC, sudden unexpected death accounts for 10% to 15% of all natural deaths in individuals 18 to 64 years old. Medications such as aspirin, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, statins, and β-blockers are recommended in guidelines to reduce cardiovascular events and even sudden death (β-blockers). However, guidelines are often underpracticed, even in high-risk patients, with noted disparities in women.
Objective:
We assessed the relation between prescription of evidence-based medications and sudden unexpected death in Wake County, NC.
Methods:
We analyzed 399 cases of sudden unexpected death for the time period March 1, 2013 to February 28, 2015 in Wake County, NC. Medications were assessed from available medical examiner reports and medical records and grouped using the third level of the Anatomical Therapeutic Chemical Classification System (ATC) codes. This study was reviewed and exempt by the University of North Carolina's institutional review board.
Results:
Among 126 female and 273 male victims, women were prescribed more medications overall than men (6.5 vs 4.3, P = 0.001); however, the use of guideline-directed therapies was not different between genders in the chronic conditions associated with sudden death. Overall, there was remarkably low use of evidence-based medications.
Conclusions:
Our findings highlight the need to improve prescribing of evidence-based medications and to further explore the relationship between undertreatment and sudden unexpected death.
More Related Videos
08:07Author Spotlight: Advancing Labor Management Through Electromyometrial Imaging for Understanding Uterine Contractions
Published on: May 26, 2023
08:42Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
Published on: May 19, 2015
Related Concept Videos
Inhaled Medications
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Endocarditis III: Medical Management
Myocarditis III: Medical Management
Pericarditis III: Medical Management